HSA approves molnupiravir
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Melco launches integrated resort hospital at Studio City Macau 2. IHH Healthcare launches ‘Global Incubator Programme’ for startups 3. NUH, Siemens to study ultrasound tech for liver disease diagnostics 4. India’s dental implant and abutment market to grow 6% annually until 2034 5. SGH to establish regional centre for robotic-assisted orthopaedic surgeryResource Center
Read Here
Advertise
Sign Up
Event News
Healthcare Asia Awards 2025 Winner: Tanupol Virunhagarun, M.D. of BDMS Wellness Clinic
Tanupol Virunhagarun, M.
